1. Home
  2. FRSX vs VCEL Comparison

FRSX vs VCEL Comparison

Compare FRSX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRSX
  • VCEL
  • Stock Information
  • Founded
  • FRSX N/A
  • VCEL 1989
  • Country
  • FRSX Israel
  • VCEL United States
  • Employees
  • FRSX N/A
  • VCEL N/A
  • Industry
  • FRSX Computer Software: Prepackaged Software
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FRSX Technology
  • VCEL Health Care
  • Exchange
  • FRSX Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • FRSX 9.0M
  • VCEL 2.1B
  • IPO Year
  • FRSX 2017
  • VCEL 1997
  • Fundamental
  • Price
  • FRSX $0.50
  • VCEL $40.25
  • Analyst Decision
  • FRSX
  • VCEL Strong Buy
  • Analyst Count
  • FRSX 0
  • VCEL 8
  • Target Price
  • FRSX N/A
  • VCEL $62.00
  • AVG Volume (30 Days)
  • FRSX 480.7K
  • VCEL 477.0K
  • Earning Date
  • FRSX 08-08-2025
  • VCEL 07-31-2025
  • Dividend Yield
  • FRSX N/A
  • VCEL N/A
  • EPS Growth
  • FRSX N/A
  • VCEL 521.85
  • EPS
  • FRSX N/A
  • VCEL 0.05
  • Revenue
  • FRSX $436,000.00
  • VCEL $238,541,000.00
  • Revenue This Year
  • FRSX N/A
  • VCEL $23.03
  • Revenue Next Year
  • FRSX N/A
  • VCEL $24.52
  • P/E Ratio
  • FRSX N/A
  • VCEL $780.58
  • Revenue Growth
  • FRSX N/A
  • VCEL 14.80
  • 52 Week Low
  • FRSX $0.45
  • VCEL $37.39
  • 52 Week High
  • FRSX $2.63
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • FRSX 45.18
  • VCEL 44.06
  • Support Level
  • FRSX $0.45
  • VCEL $39.39
  • Resistance Level
  • FRSX $0.54
  • VCEL $42.61
  • Average True Range (ATR)
  • FRSX 0.05
  • VCEL 1.73
  • MACD
  • FRSX 0.01
  • VCEL -0.15
  • Stochastic Oscillator
  • FRSX 35.50
  • VCEL 24.16

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: